{'fraction_non_alphanumeric': 0.02626641651031895, 'fraction_numerical': 0.001876172607879925, 'mean_word_length': 6.216216216216216, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
EVALUATION OF EFFECTIVENESS OF SPIRIVA RESPIMAT FOR PATIENTS WITH OCCUPATIONAL COPD

Abstract: Spiriva respimat proved to be an effective and safe medication for medical treatment of patients who suffer from moderately severe occupational COPD. Spiriva respimat has advantages of glycopyrronium bromide: functional indices (FEV1 forced expiratory volume during the first second), clinical data (dyspnea), quality of patients’ life, frequency of exacerbations, the period before the first exacerbation happens, and patient compliance.